Use discount code WELCOME35 for £35 off your first order
£0.00 0

No products in the cart.

£0.00 0

No products in the cart.

Why Injections Are Still Used for Macular Degeneration

Macular degeneration is a common eye condition, chiefly affecting those over the age of 50 – leading to partial or complete vision loss. This condition, marked by a gradual weakening of the macula (the part of the retina that provides sharp, central vision), confines millions of older individuals to a restricted lifestyle, replete with challenges and difficulties. Repeated treatments, routine check-ups, and constant care become the norm.

Despite advancements in medical science, the use of macular degeneration injections remains widespread and prevalent. This article aims to shed light on the reasons why such injections are still in use.

Ancient Practice, Modern Need

Eye injections are not a new concept. For centuries, physicians have been resorting to various invasive methods to treat or at least manage eye disorders. Macular degeneration injections are specifically designed to slow down the disease’s progression and maintain the patient’s existing level of vision.

These intraocular injections, essentially stymie the growth of abnormal, weakened blood vessels in the eyes, inhibiting them from leaking and causing scarring – leading factors in vision loss associated with macular degeneration. Despite involving certain discomfort and risks, injections remain an important part of treatment plans due to their proven effectiveness.

The Versatility of Injections

Macular degeneration injections like Avastin, Lucentis, and Eylea are versatile medications. They are formulated to not only prevent vision loss but to also improve visual acuity in some patients. Typically used for age-related macular degeneration, these medications can also treat other eye conditions such as Diabetic Macular Oedema and Diabetic Maculopathy.

Proven Effectiveness

Clinical studies and numerous anecdotal reports have repeatedly endorsed the efficacy of these injections. Many patients have reported fewer episodes of blurred or distorted vision after a regime of these injections. Moreover, patients treated with such injections reportedly maintained their vision better than those who received no treatment. These outcomes contribute to the continued use of macular degeneration injections.

Accessibility and Affordability

While newer forms of therapy, like laser treatments, are growing in popularity, such options are often more expensive, cater to a smaller patient base due to their stringent selection criteria, and rely on technology that is not readily available everywhere, particularly in rural areas.

New Solutions

Noctura 400 offers a promising solution for those seeking to avoid the discomfort and potential complications associated with macular degeneration injections. By utilising low-level light therapy during sleep, Noctura 400 effectively reduces the retina’s oxygen demand, helping to prevent the progression of diabetic eye diseases such as Diabetic Retinopathy, Diabetic Macular Edema, and Diabetic Maculopathy. With its non-invasive nature and demonstrated efficacy, Noctura 400 provides a compelling alternative for individuals looking to safeguard their vision and quality of life without the need for painful injections.

Share this post:

Related Posts

Noctura 400 showcased at Diabetes Professional Care conference 2023!

Great to work with embecta in bringing Noctura 400 to life on the stand – we met some insp...

Noctura 400 is available on the NHS!

We’re really happy that Noctura 400 is now available on the NHS, and it’s great to be feature...

Desang Diabetes Magazine Talks About Noctura 400!

If you’re enjoying relaxing over the festive period and want an informative read about Noctura ...

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.